These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32298776)

  • 1. Individual participant data meta-analyses (IPDMA): data contribution was associated with trial corresponding author country, publication year, and journal impact factor.
    Azar M; Benedetti A; Riehm KE; Imran M; Krishnan A; Chiovitti M; Sanchez T; Shrier I; Thombs BD
    J Clin Epidemiol; 2020 Aug; 124():16-23. PubMed ID: 32298776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Authorship characteristics of orthodontic randomized controlled trials, systematic reviews, and meta-analyses in non-orthodontic journals with impact factor.
    Alqaydi AR; Kanavakis G; Naser-Ud-Din S; Athanasiou AE
    Eur J Orthod; 2018 Sep; 40(5):480-487. PubMed ID: 29228139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression screening tool accuracy individual participant data meta-analyses: data contribution was associated with multiple factors.
    Wu Y; Sun Y; Liu Y; Levis B; Krishnan A; He C; Neupane D; Patten SB; Cuijpers P; Ziegelstein RC; Benedetti A; Thombs BD
    J Clin Epidemiol; 2023 Oct; 162():63-71. PubMed ID: 37619800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
    Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
    BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trials number, funding support, and intervention type associated with IPDMA data retrieval: a cross-sectional study.
    Wu IXY; Xiao F; Wang H; Chen Y; Zhang Z; Lin Y; Tam W
    J Clin Epidemiol; 2021 Feb; 130():59-68. PubMed ID: 33098991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global mapping of randomised trials related articles published in high-impact-factor medical journals: a cross-sectional analysis.
    Catalá-López F; Aleixandre-Benavent R; Caulley L; Hutton B; Tabarés-Seisdedos R; Moher D; Alonso-Arroyo A
    Trials; 2020 Jan; 21(1):34. PubMed ID: 31910857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of industry funders in oncology RCTs published in high-impact journals and its association with trial conclusions and time to publication.
    Liang F; Zhu J; Mo M; Zhou CM; Jia HX; Xie L; Zheng Y; Zhang S
    Ann Oncol; 2018 Oct; 29(10):2129-2134. PubMed ID: 30084933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No consistent evidence of data availability bias existed in recent individual participant data meta-analyses: a meta-epidemiological study.
    Tsujimoto Y; Fujii T; Onishi A; Omae K; Luo Y; Imai H; Takahashi S; Itaya T; Pinson C; Nevitt SJ; Furukawa TA
    J Clin Epidemiol; 2020 Feb; 118():107-114.e5. PubMed ID: 31654789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic characteristics of systematic reviews, meta-analyses, and randomized controlled trials in orthodontic journals with impact factor.
    Kanavakis G; Dombroski MM; Malouf DP; Athanasiou AE
    Eur J Orthod; 2016 Feb; 38(1):57-65. PubMed ID: 25788332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of Heart Failure Trials Associated With Under-Representation of Women as Lead Authors.
    Whitelaw S; Thabane L; Mamas MA; Reza N; Breathett K; Douglas PS; Van Spall HGC
    J Am Coll Cardiol; 2020 Oct; 76(17):1919-1930. PubMed ID: 33092727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The handsearching of 2 medical journals of Bahrain for reports of randomized controlled trials.
    Al-Hajeri AA; Fedorowicz Z; Amin FA; Eisinga A
    Saudi Med J; 2006 Apr; 27(4):526-30. PubMed ID: 16598332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prespecification of subgroup analyses and examination of treatment-subgroup interactions in cancer individual participant data meta-analyses are suboptimal.
    Gao Y; Liu M; Shi S; Niu M; Li J; Zhang J; Song F; Tian J
    J Clin Epidemiol; 2021 Oct; 138():156-167. PubMed ID: 34186194
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How often can meta-analyses of individual-level data individualize treatment? A meta-epidemiologic study.
    Schuit E; Li AH; Ioannidis JPA
    Int J Epidemiol; 2019 Apr; 48(2):596-608. PubMed ID: 30445577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized trials published in higher vs. lower impact journals differ in design, conduct, and analysis.
    Bala MM; Akl EA; Sun X; Bassler D; Mertz D; Mejza F; Vandvik PO; Malaga G; Johnston BC; Dahm P; Alonso-Coello P; Diaz-Granados N; Srinathan SK; Hassouneh B; Briel M; Busse JW; You JJ; Walter SD; Altman DG; Guyatt GH
    J Clin Epidemiol; 2013 Mar; 66(3):286-95. PubMed ID: 23347852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty percent of secondary publications of randomized controlled trials of drugs did not provide new results relative to the primary publication.
    Lai C; Sbidian E; Giraudeau B; Le Cleach L
    J Clin Epidemiol; 2020 Jan; 117():20-28. PubMed ID: 31546006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Citation impact was highly variable for reporting guidelines of health research: a citation analysis.
    Caulley L; Cheng W; Catalá-López F; Whelan J; Khoury M; Ferraro J; Husereau D; Altman DG; Moher D
    J Clin Epidemiol; 2020 Nov; 127():96-104. PubMed ID: 32712175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Press Releases of Drug-Related Randomized Trial Results Prior to Publication in High-Impact Journals: an Observational Study.
    Purohit U; Sacks CA; Raissi A; Hughes E; Boctor M; Manzoor S; Hodzic-Santor B; Zhu K; Raudanskis A; Ross JS; Fralick M
    J Gen Intern Med; 2023 Nov; 38(14):3107-3114. PubMed ID: 37532876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends and comparison of female first authorship in high impact medical journals: observational study (1994-2014).
    Filardo G; da Graca B; Sass DM; Pollock BD; Smith EB; Martinez MA
    BMJ; 2016 Mar; 352():i847. PubMed ID: 26935100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Authors of clinical trials reported individual and financial conflicts of interest more frequently than institutional and nonfinancial ones: a methodological survey.
    Hakoum MB; Jouni N; Abou-Jaoude EA; Hasbani DJ; Abou-Jaoude EA; Lopes LC; Khaldieh M; Hammoud MZ; Al-Gibbawi M; Anouti S; Guyatt G; Akl EA
    J Clin Epidemiol; 2017 Jul; 87():78-86. PubMed ID: 28412465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.